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Fibroblast growth factor 18 (FGF18) has been shown to regulate chondrocyte proliferation and differentiation by signaling through FGF
receptor 3 (FGFR3) and to regulate osteogenesis by signaling through other FGFRs. Fgf18−/− mice have an apparent delay in skeletal
mineralization that is not seen in Fgfr3−/− mice. However, this delay in mineralization could not be simply explained by FGF18 signaling to
osteoblasts. Here we show that delayed mineralization in Fgf18−/− mice was closely associated with delayed initiation of chondrocyte
hypertrophy, decreased proliferation at early stages of chondrogenesis, delayed skeletal vascularization and delayed osteoclast and osteoblast
recruitment to the growth plate. We further show that FGF18 is necessary for Vegf expression in hypertrophic chondrocytes and the perichondrium
and is sufficient to induce Vegf expression in skeletal explants. These findings support a model in which FGF18 regulates skeletal vascularization
and subsequent recruitment of osteoblasts/osteoclasts through regulation of early stages of chondrogenesis and VEGF expression. FGF18 thus
coordinates neovascularization of the growth plate with chondrocyte and osteoblast growth and differentiation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Fibroblast growth factor 18 (FGF18); Skeletal development; Growth plate; Chondrocyte; Osteoblast; Periosteum; Perichondrium; Vascular developmentIntroduction
Skeletogenesis in vertebrates is achieved through two
distinct developmental processes. Cranial bones and medial
clavicles are formed through intramembranous ossification,
while facial bones and the appendicular skeleton develop
through endochondral ossification (Erlebacher et al., 1995;
Karsenty and Wagner, 2002). Shortly after limb bud formation,
endochondral ossification is initiated from mesenchymal
condensations. Differentiation of condensed mesenchyme
gives rise to chondrocytes centrally and osteoprogenitors in
the perichondrium. Proliferating chondrocytes and subsequent-
ly differentiated hypertrophic chondrocytes elaborate an
extracellular matrix (ECM) that forms a cartilaginous template
for future mineralization.⁎ Corresponding author.
E-mail address: dornitz@wustl.edu (D.M. Ornitz).
1 Current address: Department of Medicine, Washington University School of
Medicine, USA.
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.08.071Fibroblast growth factors (FGFs) are signaling molecules
that are essential regulators of endochondral bone growth. FGF
receptor 3 (FGFR3) is expressed in proliferating chondrocytes
where it regulates proliferation and differentiation. At late
embryonic stages and during postnatal skeletal growth, FGFR3
signaling suppresses chondrocyte proliferation and hypertro-
phic differentiation (Goldring et al., 2006; Ornitz and Marie,
2002). However, during early skeletal development, FGFR3 is
mitogenic for chondrocytes and inhibits hypertrophic differen-
tiation (Iwata et al., 2000). FGF18 is expressed in the
perichondrium and in joint spaces and has been identified as a
potential ligand for FGFR3 (Davidson et al., 2005; Xu et al.,
2000). At late embryonic stages, both Fgf18−/− and Fgfr3−/−
mice have an expanded proliferating and hypertrophic chon-
drocyte zone, associated with increased Indian hedgehog (IHH)
expression and signaling (Colvin et al., 1996; Liu et al., 2002;
Naski et al., 1998; Ohbayashi et al., 2002). These similarities
suggest that FGF18 is a functional ligand for FGFR3. However,
Fgf18−/− mice have reduced bone length and show an
approximate 2-day delay in the onset of skeletal mineralization,
phenotypes that are not observed in Fgfr3−/− mice (Liu et al.,
81Z. Liu et al. / Developmental Biology 302 (2007) 80–912002). This suggests that FGF18 signals to other FGFRs to
regulate the onset of the mineralization process. The delayed
mineralization phenotype in Fgf18−/− mice could be explained
by either a direct effect of FGF18 on the chondrocyte and
osteoblast or an indirect effect of FGF18 on, for example,
vascularization of the growth plate.
The hypertrophic chondrocyte zone is an avascular structure
that must be invaded by blood vessels that arise from the
perichondrium. This neovasculogenesis of the central hyper-
trophic zone allows hematopoietic-derived osteoclasts/chon-
droclasts to enter and progressively erode the cartilaginous
matrix (Goldring et al., 2006; Kronenberg, 2003; Wagner and
Karsenty, 2001; Zelzer and Olsen, 2005). Along with the
vasculature, perichondrial-derived osteoblasts eventually re-
place the eroded cartilaginous matrix with trabecular bone. Such
a sequence of events relies on the precise coupling of
chondrogenesis, osteogenesis and vascularization. However, it
is still unclear how these different developmental processes are
coordinated in a temporally and spatially correct fashion.
The endothelial cell-specific mitogen vascular endothelial
growth factor (VEGFA) is an important regulator of vasculogen-
esis and angiogenesis during endochondral ossification. VEGFA
binds to its tyrosine kinase receptors VEGFR1 (Flt1, VR1) and
VEGFR2 (Flk1, VR2) (Yancopoulos et al., 2000). Administra-
tion of a soluble receptor to inhibit VEGF suppresses vascular
invasion and results in bone length reduction and hypertrophic
zone expansion (Gerber et al., 1999). Conditional targeting of
VEGFA or VEGF164/188 in type II collagen-expressing cells
and descendants produces similar phenotypes (Maes et al., 2002;
Zelzer et al., 2002). These data demonstrate that VEGF/VEGFR
signaling is essential for skeletal vascularization.
In this study, we demonstrate that the delayed ossification
observed in Fgf18−/− mice was closely associated with delayed
initiation of chondrocyte hypertrophy, skeletal vascularization
and osteoclast recruitment, and decreased chondrocyte prolif-
eration. We show that expression of Vegf in hypertrophic
chondrocytes was also delayed in Fgf18−/− mice with
concurrent decreased expression of Vegfr1. In an in vitro limb
explant culture system, we demonstrated that FGF18 was
sufficient to induce Vegf expression. These findings support a
model in which FGF18 regulates skeletal vascularization and
osteoclast recruitment through regulation of VEGF signaling.
Combined with previous data, we conclude that FGF18 is an
essential regulator of skeletogenesis by coordinating chondro-




Skeletons were prepared as described previously (Liu et al., 2002). For
postnatal day 0 (P0) skeletal preparations, carcasses were skinned and
eviscerated, and then soaked in acetone for 12–24 h, cleared in 2% KOH
(12–24 h), stained with alizarin red S and alcian blue (12–24 h), cleared in
1% KOH/20% glycerol, and stored in glycerol. For embryo skeleton
preparations, fetuses were skinned and eviscerated, stained with alizarin red
S and alcian blue (12–24 h), cleared in 1% KOH/20% glycerol, and stored in
glycerol.Histological and immunohistochemical analysis
Tissues were fixed in 4% paraformaldehyde/PBS, decalcified if necessary
in EDTA or Decalcifying Solution (Stephens Scientific), and embedded in
paraffin. Sections were stained with hematoxylin and eosin (H&E), von
Kossa and TRAP. For PECAM (CD31) immunohistochemistry, sections were
deparaffinized with two changes of xylene for 10 min each, then rehydrated
through 100%, 95%, 75% and 50% ethanol washes for 5 min each. After
rinsing in PBS, sections were treated with 0.1% trypsin at 37 °C for 10 min
and rinsed in three changes of PBS for 5 min each. Sections were blocked in
5% serum for 30 min and then incubated with anti-PECAM antibody (BD
Pharmingen) at 4 °C for 12–24 h, rinsed with PBS, and incubated with
secondary antibody (Chemicon) at RT for 1 h. Fluorescent microscopic
images were taken using a Hamumatsu camera and AxioVison3.0 software
(Zeiss).
In situ hybridization
In situ hybridization was performed as described previously (Liu et al.,
2002). The plasmids used for generating P33-labeled riboprobes were generously
provided by: B. Olsen (Collagen X, Vegfr1, Vegfr2); G. Karsenty (Vegf); G.
Andersson (Trap); Z. Werb (Mmp9); A. McMahon (Ihh); H. Kronenberg
(Pth1r); B. de Crombrugghe (Sox9, Collagen 1).
Real-time quantitative PCR
Total RNA was extracted from E16.5 skinned autopods using the RNeasy
Mini kit (Qiagen, Valencia, CA). Two RNA samples from each genotype were
pooled together, 1 μg of total RNA was used for oligo dT or random
hexanucleotide-primed cDNA synthesis. cDNAs were added to 25 μl reaction
mixtures containing 12.5 μl of SYBR Green master mix (Applied Biosystems,
Foster City, CA), 0.25 U of UDP-N-glycosidase (Invitrogen), and 400 nM gene-
specific primers. A melting curve was used to identify a temperature where only
the amplicon, and not primer dimers, accounted for the SYBR green-bound
fluorescence. Assays were performed in quadruplicate with an ABI Prism 7700
Sequence Detector (Applied Biosystems). All data were normalized to an
internal standard (GAPDH; comparative CT method, User Bulletin 2, Applied
Biosystems).
Primer sequences:Gapdh (5′ TGCACCACCAACTGCTTAG 3′; 5′ GGAT-
GCAGGGATGATGTTC 3′), Flt1 (5′ GAGGAGGATGAGGGTGTCTATA-
GGT 3′; 5′ GTGATCAGCTCCAGGTTTGACTT 3′) (Shih et al., 2002), Flk1
(5′ AGGTCACCATTCATCGCCTC 3′; 5′ GAAATCGACCCTCGGCATG 3′),
Pecam1 (5′ AGGAAAGCCAAGGCCAAACA 3′; 5′ CATTAAGGGAGCC-
TTCCGTTCT 3′) (Fitzsimmons et al., 2000), VegfA (5′ GGAGATCCTTC-
GAGGAGCACTT 3′; 5′ GGCGATTTAGCAGCAGATATAAGAA 3′) (Shih
et al., 2002), VegfB (5′ GAAGAAAGTGGTGCCATGGATAG 3′; 5′ CCCAT-
GAGTTCCATGCTCAGA 3′) (Mills et al., 2001).
PCR conditions for Flt1 and Flk1: 50 °C 2 min; 95 °C 10 min; 35 (95 °C
15 s; 60 °C 1 min). PCR conditions for VegfA, VegfB: 95 °C 3 min; 40 (95 °C
30 s; 60 °C 30 s; 72 °C 30 s).
Embryonic limb explant cultures and whole mount
β-galactosidase staining
Limb explant cultures were carried out essentially as described (Minina et
al., 2001) with minor modifications. Forelimb cartilage was dissected from
E14.5 VEGF-LacZ or wild type mouse embryos (Miquerol et al., 1999) and
placed at the air-fluid interface on Transwell filters (Corning) containing
DMEM, 10% fetal calf serum (GibcoBRL), antibiotic/antimycotic solution
(Sigma) and 2 μg/ml heparin. Media was supplemented with 250 ng/ml
recombinant FGF10 (Peprotech), recombinant FGF18 (Peprotech), or BSA.
Explants were cultured for 24 h or 48 h at 37°C/5% CO2 under humidified
conditions. For whole mount β-galactosidase staining, limb explants were
harvested on Day 2 and fixed in 0.2% glutaraldehyde, 5 mM EGTA pH 7.3,
100 mM MgCl2, 0.02% NP40, 0.01% sodium deoxycholate in PBS. After
washing with PBS, explants were incubated for 4–5 h at 24 °C in β-
galactosidase staining buffer containing 1 mg/ml X-gal, 5 mM K3Fe(CN)6,
82 Z. Liu et al. / Developmental Biology 302 (2007) 80–915 mM K4FE(CN)6 ˙3H20. Stained explants were rinsed in PBS prior to digital
photography with an Olympus DP70 camera.
Results
Delayed ossification in Fgf18−/− mice
Examination of skeletal preparations from Fgf18−/− mice
demonstrated delayed ossification in both intramembranous and
endochondral skeletal elements. Cranial ossification begins
around E14.5 in wild type mice. At E15.5, both the frontal and
parietal bones of the cranium were clearly mineralized in wild
type mice, as shown by Alizarin Red staining (Fig. 1A). In
Fgf18−/− mice, Alizarin Red staining was absent in the cranium
at this stage, while the maxilla, premaxilla and the mandible
showed significant mineralization (Fig. 1A). However, the
mandible was still underdeveloped in Fgf18−/− mice comparedFig. 1. Morphological analysis of skeletal ossification. (A) Alizarin red-stained skull f
delayed ossification in the Fgf18−/− mutant. (B) Alizarin red- and alcian blue-stained
Note the delayed ossification in the cranium of the Fgf18−/− mutant. (C) Alizarin re
Fgf18−/− embryo (right). Note the deformed ribs and poorly ossified ribs of the Fgf18−
littermate (left) and an Fgf18−/− embryo (right). (E) Forelimbs from an E17.5 wild typ
of the autopod elements of the Fgf18−/− embryo at this stage (arrow).with that of wild type embryos (Fig. 1A). One day later at
E16.5, mineralization of the Fgf18−/− cranium was not yet
initiated (Fig. 1B). The developing ribs also showed delayed
mineralization. At E16.5 in wild type embryos, the mineralized
portion of the ribs extended almost halfway towards the ventral
midline, but in Fgf18−/− mutants, ribs were deformed and only
the dorsal most portions were mineralized (Fig. 1C). At E17.5,
the rib deformity in Fgf18−/− mutants persisted and minerali-
zation had progressed to a lesser degree compared to wild type
littermates (Fig. 1D).
In addition to the ossification defects in the axial skeletons,
the appendicular skeleton also showed delayed ossification (Liu
et al., 2002). At E17.5, the mineralized portions of the limbs in
Fgf18−/− embryos were significantly shorter than those of wild
type littermates (Fig. 1E). Additionally, ossification centers in
the metacarpal bones were present in wild type mice, but were
not initiated in Fgf18−/− embryos at this stage (Fig. 1E). Similarrom an E15.5 wild type littermate (left) and an Fgf18−/− embryo (right) showing
skull from an E16.5 wild type littermate (left) and an Fgf18−/− embryo (right).
d- and alcian blue-stained ribs from an E16.5 wild type littermate (left) and an
/− embryo. (D) Alizarin red- and alcian blue-stained ribs from an E17.5 wild type
e littermate (upper) and an Fgf18−/− embryo (lower). Note there is no ossification
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development and in the zeugopod and stylopod at earlier stages
of development (Liu et al., 2002, and data not shown). These
data demonstrated that the onset of ossification in Fgf18−/−
mice was delayed in skeletal elements involving both
endochondral and intramembranous ossification.
In endochondral bone growth, the progression of chondro-
cyte development results in mineralization of the cartilaginous
matrix of the completely differentiated hypertrophic chondro-
cyte (Karsenty and Wagner, 2002). Cartilage matrix minerali-
zation is thought to be essential for subsequent vascular invasion
and ossification. Because of the observed delay in skeletal
ossification, it was important to determine whether there was
also a delay in mineralization of hypertrophic chondrocytes and
formation of the bone collar. Von Kossa staining of skeletal
elements was used to examine the extent of ossification. In the
autopods, mineralization of the metatarsal elements in wild type
embryos was seen in the middle of the cartilage element at E16.5
(Fig. 2A). In Fgf18−/− metatarsals, no von Kossa staining was
observed even though hypertrophic chondrocytes were present
centrally (Fig. 2B). Furthermore, the perichondrium was thinner
in Fgf18−/− metatarsals, suggesting a defect in bone collar
formation. We next examined the expression of the bone-
specific marker Col1 to measure the extent of the defect. At
E16.5, wild type metatarsal elements showed strong and
localized Col1 expression in the perichondrium adjacent to the
hypertrophic chondrocytes (Fig. 2C), indicating the presence of
osteoblasts. However, in Fgf18−/− metatarsals, only low-level
expression of Col1 was detected (Fig. 2D). One day later at
E17.5, mineralization was initiated in Fgf18−/−metatarsals (Fig.
2F), but the extent of mineralization was significantly less than
that of wild type littermates (Fig. 2E). Examination of the
perichondrium showed significant mineralization in wild type
metatarsal elements (Figs. 2E, G). However, at E17.5, Fgf18−/−
metatarsal elements still showed minimal perichondrial/perios-
teal mineralization (Figs. 2F, H). Only a single layer of cuboidal
osteoblasts was present in the perichondrium of Fgf18−/−
metatarsal elements compared to several layers in wild type
controls (Figs. 2G, H). This histology is consistent with less
bone collar formation as shown by Col1 expression (Figs. 2C,
D). These data demonstrate that in Fgf18−/− mice, both
perichondrial/periosteal bone collar formation and hypertrophic
chondrocyte mineralization were delayed.
Delayed initiation of chondrocyte hypertrophy in
Fgf18−/− mice
The observed delayed mineralization of hypertrophic
chondrocytes suggested a more general delay in chondrocyte
differentiation. Consistent with this, the hypertrophic chondro-
cyte portion of the skeletal elements in the autopods shown in
Fig. 2 appeared to be significantly narrower in Fgf18−/− mice
compared to wild type littermates, suggesting a possible delay
in the initiation of chondrocyte hypertrophy (Figs. 2A–F). To
confirm this, the extent of chondrocyte hypertrophy was
evaluated by examining the expression of the hypertrophic
chondrocyte-specific marker, type X collagen (ColX). At E15.5,the developing metatarsals showed a narrower domain of ColX
expression in Fgf18−/− autopods compared to those of wild type
littermates (Figs. 2I, J), consistent with the histology and
delayed appearance of von Kossa-positive cells in the Fgf18−/−
autopods.
We next examined proximal long bones to see if this delayed
initiation of chondrocyte hypertrophy also existed in other
skeletal elements. Histological analysis showed that the size of
the hypertrophic chondrocyte zone in E14.5 Fgf18−/− humeri
was significantly shorter than that in wild type littermates
(0.53 mm versus 0.69 mm, respectively; n=2 mice for each
genotype, 6 sections, P<0.05) (Figs. 3A, B). Similar delayed
initiation of chondrocyte hypertrophy was also observed in
other long bones (data not shown). These data demonstrate that
FGF18 positively regulates the initiation of chondrocyte
hypertrophy during early chondrogenesis and is likely to
function in both proximal and distal skeletal elements.
To further characterize the nature of the chondrocyte
phenotypes, we examined the expressions of several molecules
that are important for the development of early chondrocytes. In
situ hybridization experiments showed similar levels of
expression of Sox9 and the PTHrP receptor (Pth1r) in the
growth plates of both Fgf18−/− and wild type mice (Figs. 3C–
F). However, the expression of Indian hedgehog (Ihh), an
important signaling molecule that controls the proliferation of
chondrocytes, was decreased in the early hypertrophic chon-
drocytes of the E14.5 humerus from Fgf18−/− mice compared to
that of wild type littermates (Figs. 3G, H). Similar down-
regulation of Ihh was also observed in the tibia of Fgf18−/−
mice (data not shown).
Decreased chondrocyte proliferation in E14.5 Fgf18−/− mice
Proliferation and differentiation of chondrocytes in the
epiphyseal growth plate must be coordinated to keep long bone
growth in balance. The delayed ossification and initiation of
chondrocyte hypertrophy in Fgf18−/− mice could be due to a
decreased pool of available proliferating chondrocytes. This
possibility suggests that FGF18 could positively regulate
chondrocyte proliferation during early chondrogenesis. To
test this hypothesis, we assessed the proliferation rates of
reserve and proliferating chondrocytes in E14.5 Fgf18−/−
embryos. Proliferating cells were identified by immunohisto-
chemical staining of phospho-histone 3 (pH3) (Fig. 4). pH3-
positive cells in the proliferating zones of the distal tibia and
humeri were decreased by 26% (P<0.05) and 31% (P<0.05),
respectively (Figs. 4A–B and Table 1). However, chondrocytes
in the reserve zones of these growth plates did not show
statistically significant changes in the rate of proliferation
(Table 1). Chondrocytes in the developing E14.5 metatarsals
also showed markedly decreased rates of proliferation (Figs.
4C, D and Table 1). These data suggest that FGF18 promotes
chondrocyte proliferation during early chondrogenesis, and are
consistent with the observation of decreased Ihh expression in
the growth plates of E14.5 Fgf18−/− mice (Figs. 3G, H). Cell
death was assayed by TUNEL labeling. Very few apoptotic
cells were observed at this stage of development and there was
Fig. 2. Analysis of mineralization and initiation of chondrocyte hypertrophy in the developing autopod. (A, B, E–H) Von Kossa-stained sections to visualize
mineralized tissue. (A, B) Metatarsal bones from an E16.5 wild type (A) and Fgf18−/− (B) embryo. Note there is no mineralization in Fgf18−/− metatarsals and fewer
hypertrophic appearing cells. (C, D) In situ detection of Col1 mRNA on sections of metatarsal bones from an E16.5 wild type (C) and Fgf18−/− (D) embryo. (E, F)
Metatarsal bones from an E17.5 wild type (E) and Fgf18−/− (F) embryo. Note decreased mineralization of hypertrophic chondrocytes and less periosteal mineralization
(arrows) in Fgf18−/− metatarsals. (G, H) High power view of the boxed area in panels E and F showing a thinner periosteum (green line) and an unmineralized bone
collar in Fgf18−/− mice. (I, J) In situ detection of ColX on sections of metatarsal bones from an E15.5 wild type (I) and Fgf18−/− embryo (J) showing a narrower
hypertrophic zone in the Fgf18−/− tissue. r, reserve chondrocytes; p, proliferating chondrocytes; h, hypertrophic chondrocytes. Panels A–H, I, J were photographed
through a 10× objective. Panels G, H were photographed through a 20× objective and digitally magnified.
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Fig. 3. Analysis of the initiation of chondrocyte hypertrophy in E14.5 wild type and Fgf18−/−mice. (A, B) Hematoxylin and eosin-stained sections of the humerus from
an E14.5 wild type embryo (A) and an Fgf18−/− (B) embryo. Note the decreased length of the Fgf18−/− hypertrophic zone relative to that of the control. (C–H) In situ
detection of Sox9 (C, D), PTHrP receptor (Pth1r) (E, F) and Indian Hedgehog (Ihh) (G, H) in the developing humeri growth plates from E14.5 wild type embryos (C,
E, G) and Fgf18−/− embryos (D, F, H). All panels were photographed through a 10× objective.
85Z. Liu et al. / Developmental Biology 302 (2007) 80–91no apparent difference between control and Fgf18−/− mice
(data not shown).
Delayed osteoclast recruitment into the hypertrophic
chondrocyte zone in Fgf18−/− mice
Our data indicate that the decreased chondrocyte prolifera-
tion/hypertrophy and mineralization may be one mechanism
resulting in delayed ossification in Fgf18−/− mice. However,
definitive ossification requires vascular invasion of the
avascular cartilaginous template allowing osteoblasts and
osteoclasts to enter the central hypertrophic chondrocyte region.
Previous studies on Fgf18−/− mice proposed that the delay in
osteoblast colonization of the central hypertrophic zone resultedfrom either a direct effect of FGF18 on osteoblast proliferation
or an effect on vascular invasion of the growth plate (Liu et al.,
2002). Because both osteoblasts and osteoclasts require
vasculature to gain entry into the hypertrophic zone (Karsenty
and Wagner, 2002; Vu et al., 1998), we could test whether
delayed vascular invasion could contribute to the observed
phenotype by examining whether osteoclast recruitment was
also delayed in the Fgf18−/− skeletons.
Osteoclasts/chondroclasts express tartrate-resistant acidphos-
phatase (TRAP) and matrix metalloproteinase 9 (MMP9)
(Karsenty,2003;Roodman,1996;Vuetal.,1998).Theexpression
ofMmp9 is required for normal degradation of the cartilaginous
matrix and vascularization of the hypertrophic zone. Consistent
with this, Mmp9−/− mice have decreased angiogenesis and an
Fig. 4. Decreased chondrocyte proliferation in the growth plates of E14.5 mice. (A–D) proliferating cells were identified by immunostaining with a pH3 antibody (red),
nuclei were stained with DAPI (blue). (A, B) pH3 staining of E14.5 distal humeri growth plates from a wild type (A) and an Fgf18−/− (B) embryo. (C, D) pH3 staining
of E14.5 metatarsals from a wild type embryo (C) and an Fgf18−/− (D) embryo. r, reserve chondrocytes; p, proliferating chondrocytes; h, hypertrophic chondrocytes.
All panels were photographed through a 10× objective.
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E15.5, when vascularization is initiated in the femur of wild
type mice, both Trap and Mmp9 transcripts can readily be
detected in the vascular invasion front (Figs. 5A, C). However,
expressions of Trap and Mmp9 were significantly decreased in
the femur of Fgf18−/− mice (Figs. 5B, D). By E16.5, in the
developing humerus, endothelial cells have already populated
the trabecular region and Trap-positive cells mostly reside at
the cartilage-bone interface. In Fgf18−/− mice, there were
fewer Trap-expressing cells in this region (17.5±2.6 in wild
type versus 12±2.2 in Fgf18−/−, P<0.01 and Figs. 5E, F).
These data demonstrate that osteoclast infiltration into the
hypertrophic zone was delayed in Fgf18−/− mice.
Reduced expression of Vegf and Vegf receptors in
Fgf18−/− mice
Vascular endothelial growth factor (VEGF) signaling is
essential for skeletal vascularization (Maes et al., 2002; Ornitz,Table 1
Proliferation index for E14.5 growth plates
Growth plate a Genotype N b pH3+/mm2 c Control (%) P value
Distal tibia PZ +/+ 4 56.5±5.4 74 0.03
−/− 4 42±8.3
Distal tibia RZ +/+ 4 61.6±15.1 89 0.23
−/− 4 54.8±5.8
Distal humerus PZ +/+ 6 45.5±17.5 69 0.03
−/− 8 31.4±8.3
Distal humerus RZ +/+ 6 55.3±15.1 78 0.06
−/− 8 43.1±12.4
Metatarsal +/+ 5 58.5±9.9 63 0.002
−/− 6 37±8.6
a PZ, proliferating chondrocyte zone; RZ, reserve chondrocyte zone.
b Number of sections derived from at least 2 pairs of animals.
c pH3-positive cells per mm2.2005; Zelzer et al., 2002; Zelzer and Olsen, 2005). The delayed
ossification and osteoclast recruitment in Fgf18−/− mice
suggested that FGF18 might regulate skeletal vascularization
through VEGF signaling. To test this hypothesis, we examined
the expression of Vegf and Vegf receptors (Vegfrs) in developing
skeletal elements. In wild type E15.5 autopods, Vegf expression
was present in hypertrophic chondrocytes and in interdigital
mesenchyme (Figs. 6A, A′). In Fgf18−/− autopods, the
expression of Vegf was reduced, especially in the hypertrophic
chondrocyte region (Figs. 6B, B′). Consistent with this,
quantitative real-time PCR analysis of E16.5 autopods showed
a 37% decrease in VegfA expression (Fig. 6G). However, in
proximal long bones where chondrocytes have already
undergone hypertrophy, the expression level of VegfA in
Fgf18−/− mice appeared relatively normal (Liu et al., 2002).
These data suggest that FGF18 may regulate Vegf expression in
hypertrophic chondrocytes and the perichondrium at early
stages of chondrocyte development.
The expression of Vegfrs is regulated by VEGF signaling,
and the level of Vegfr expression serves as a measure of the
strength of the VEGF signal (Barleon et al., 1997; Gerber et al.,
1999; Shen et al., 1998; Zelzer et al., 2002). To test whether loss
of FGF18 affects VEGF signaling, we compared the expression
of Vegfr1 and Vegfr2 in wild type and Fgf18−/− mice. At E14.5
in the autopods, expressions of both Vegfr1 and Vegfr2 were
detected in interdigital mesenchyme surrounding the metacarpal
cartilage in wild type mice (Figs. 6C, E). In Fgf18−/− mice, the
intensity of the Vegfr1 and Vegfr2 signals was weaker compared
to wild type littermates (Figs. 6D, F). The expression of Vegfr1
and Vegfr2 was quantified using real-time PCR. At E16.5, both
Vegfr1 and Vegfr2 were down-regulated, consistent with the
ISH data. Interestingly, the extent of Vegfr1 down-regulation
(77% of wild type levels) was greater than Vegfr2 (46% of wild
type levels) (Fig. 6G). These data suggest that FGF18 may
differentially affect Vegfr1 and Vegfr2 expression.
Fig. 5. Delayed osteoclast recruitment in Fgf18−/− mice. (A–D) In situ detection of Trap (A, B) and Mmp9 (C, D) in the developing E15.5 femur. Note that fewer
osteoclasts are present in the vascular front of the Fgf18−/− (B, D) compared to control (A, C) femora. (E, F) In situ detection of Trap in the developing E16.5 humerus
from a wild type (E) and Fgf18−/− (F) mouse, showing fewer Trap-positive cells at the bone–cartilage interface of the Fgf18−/− humerus. All panels were
photographed through a 10× objective.
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plate results in decreased vascularization, we examined vascular
formation in E14.5 forelimbs. At this stage of development,
Fgf18 is expressed in the perichondrium, as shown by
immunostaining for the β-galactosidase gene introduced into
the Fgf18 locus (Liu et al., 2002) (Figs. 7A, B). The pattern of
β-galactosidase expression indicates sites where Fgf18 is
normally expressed. As visualized by PECAM immunohisto-
chemistry, blood vessels were present in close proximity to
developing hypertrophic chondrocytes in the humerus of wild
type mice (Fig. 7A). However, the density of PECAM-
expressing endothelial cells was significantly decreased in
age-matched Fgf18−/− mice (Fig. 7B). These data demonstrate
that FGF18 is required for VEGF expression and subsequent
vascularization in the perichondrium.
FGF18 induces Vegf-LacZ expression in limb explant cultures
To test whether FGF18 could affect VEGF signaling more
directly, we used a limb explant culture system. E14.5 forelimbs
from mice heterozygous for a β-galactosidase-tagged allele of
Vegf (Miquerol et al., 1999) were cultured with bovine serum
albumin (BSA), FGF10, or FGF18. Vegf expression levels, as
indicated by β-galactosidase staining intensity, were signifi-
cantly increased in limbs treated with FGF18 compared with
those treated with BSA or FGF10 (Figs. 7C–H). Furthermore,
only FGF18-treated explants showed β-galactosidase activity inthe perichondrium (Fig. 7H). Real-time quantitative PCR
analysis was used to directly measure Vegf expression in wild
type explants treated with BSA, FGF10, or FGF18. This
analysis showed that VegfA expression was increased approx-
imately 29% (P=0.055) after 24 h of FGF18 treatment (Fig. 7I).
Though not statistically significant (P=0.14), VegfB may be
upregulated as well. FGF10 did not induce expression of either
VegfA or VegfB when compared to treatment with BSA (Fig. 7I).
These results demonstrate that FGF18 is sufficient to induce
Vegf expression in the limb. Furthermore, since FGF18 was
active and FGF10 showed no activity, it indicated that a
mesenchymal FGFR responded to the FGF18 signal. Since
VEGF is an important stimulator of skeletal angiogenesis
(Zelzer et al., 2002), these data support the hypothesis that
FGF18 regulates vascularization of developing bone by
positively regulating VEGF expression and signaling.
Discussion
In this study, we have extended the analysis of FGF18
function in skeletal development to show that at early
embryonic stages (E14–E15), FGF18 signaling regulates
chondrocyte proliferation, the onset of hypertrophic chondro-
cyte differentiation, vascular development in mesenchyme
surrounding developing skeletal elements, and vascular inva-
sion of the hypertrophic chondrocyte zone. These studies
support a model in which FGF18 signals to FGFR3 in
Fig. 6. Expression of Vegf and Vegf receptors in the developing autopod. (A, B) In situ detection of VegfA in the developing E15.5 autopod from a wild type (A) and
Fgf18−/− (B) mouse. Arrow indicates VegfA expression in hypertrophic chondrocytes. r, reserve chondrocytes; p, proliferating chondrocytes; h, hypertrophic
chondrocytes. (A′, B′) insets showing high magnification (40× objective) DIC images of the proliferating–hypertrophic chondrocyte junction of the darkfield overlays
shown in panels A and B. Note that silver grains are visible in wild type hypertrophic chondrocytes in panel A′. (C, D) In situ detection of Vegfr1 in the developing
E14.5 autopod from a wild type (C) and Fgf18−/− (D) mouse. (E, F) In situ detection of Vegfr2 in the developing E14.5 autopod from a wild type (E) and Fgf18−/− (F)
mouse. Note that the Vegfr1 and Vegfr2 expression domains in the Fgf18−/− autopod are restricted to the middle region of the interdigital mesenchyme. Panels A–F
were photographed through a 10× objective. (G) Real-time quantitative PCR analysis of VegfA, Vegfr1 and Vegfr2 expression. Data are expressed as the percentage of
each individual gene's expression level (±SEM) in Fgf18−/− autopod tissue normalized to Gapdh expression, relative to the gene's expression level in wild type tissue
normalized to Gapdh expression. (*P<0.0001; **P=0.001; ***P=0.005).
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carry out its developmental and physiological role.
Regulation of chondrocyte proliferation and hypertrophy at
early and late developmental stages
Skeletal development is unique in that it begins in
midgestation and continues postnatally until puberty. Gain offunction mutations in FGFR3 in humans and mice result in
skeletal dwarfism by negatively regulating chondrocyte prolif-
eration. The dwarfism phenotype is manifest during late
embryogenesis and throughout the postnatal skeletal growth
period. During this period of development, FGFR3 has been
shown to negatively regulate chondrocyte proliferation and
hypertrophic differentiation by activating STAT1 signaling
pathways (Sahni et al., 1999, 2001). However, in vitro,
Fig. 7. FGF18 regulates Vegf expression in limb explant cultures. (A, B) Fluorescent immunohistochemical detection of perichondrial vasculature in the humeri of an
E14.5 Fgf18−/+ (A) and Fgf18−/− (B) mouse. Vascular endothelial cells were detected by immunostaining with a PECAM antibody (red). FGF18-expressing cells were
detected by immunostaining with an antibody to β-galactosidase (blue). p, proliferating chondrocytes; h, hypertrophic chondrocytes. (C–H) Heterozygous Vegf-LacZ
mouse forelimbs were explanted at E14.5 and cultured in the presence of BSA (C, F), FGF10 (D, G) or FGF18 (E, H) for 48 h. (F–H) Sections of boxed area in panels
C–E showing β-galactosidase enzyme activity in hypertrophic chondrocytes. Note that FGF18-treated explant showed increased β-galactosidase activity, indicating
that specific activation of mesenchymal FGF receptors can induce Vegf expression (E, H). Arrow points to β-galactosidase activity in the perichondrium of FGF18-
treated explants (H). (I) Real-time quantitative RT-PCR analysis of VegfA and VegfB expression in wild type explants treated with BSA, FGF10 or FGF18. Data are
expressed as the percentage of each individual gene's expression level in FGF10- or FGF18-treated samples, relative to the gene's expression level in BSA-treated
samples (±SEM). All data were normalized to Gapdh expression before comparison. (*P=0.055).
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1996). Examination of mice harboring an activating mutation in
FGFR3 revealed that early in development, FGFR3 functions to
promote chondrocyte proliferation and decrease differentiation
(Iwata et al., 2000). This suggests that signaling through FGFR3
has a biphasic role during chondrocyte development: first,
promoting chondrocyte proliferation at early embryonic stages;
and later, acting to suppress chondrocyte proliferation. Consis-
tent with this model, cultured limb mesenchymal cells from
Fgfr3−/− mice fail to differentiate into chondrocytes and do not
proliferate in the presence of FGF18 (Davidson et al., 2005).In the initial analysis of Fgf18−/− mice, it was noted that at
late developmental stages, the hypertrophic chondrocyte zone
was expanded, with histology similar to that seen in mice
lacking Fgfr3. This was consistent with a model in which
FGF18 signaled through FGFR3 to negatively regulate
chondrocyte proliferation and differentiation during late
embryonic and early postnatal development. In this study, we
examined the Fgf18−/− phenotype at early embryonic stages
and found that the size of the early hypertrophic chondrocyte
zone was significantly decreased at E14.5, suggesting de-
creased chondrocyte proliferation and a delay in the initiation
90 Z. Liu et al. / Developmental Biology 302 (2007) 80–91of chondrocyte hypertrophy. Indeed, quantification of prolifer-
ating cells showed significantly decreased chondrocyte prolif-
eration in E14.5 Fgf18−/− growth plates. This paradoxical
effect on chondrocyte proliferation and differentiation supports
a model in which chondrocytes at different stages of
development may switch their cellular responsiveness to
FGF18/FGFR3 signaling from a mitogenic/differentiation
response to a non-mitogenic/reduced differentiation response.
Alternatively, the shortened hypertrophic chondrocyte zone
could be explained by a more general delay in endochondral
bone development.
Previous studies showed that FGF18 and FGFR3 inhibited
Ihh expression in pre-hypertrophic chondrocytes at late
embryonic and postnatal stages (Liu et al., 2002; Naski et al.,
1998). The primary role of IHH is to regulate chondrocyte
maturation through induction of PTHrP (St-Jacques et al.,
1999). During early chondrogenesis, IHH also stimulates
chondrocyte proliferation in a largely PTHrP-independent
pathway (Karp et al., 2000). Our observation of the concomitant
decreases in both Ihh expression and chondrocyte proliferation
suggests that FGF18/FGFR3 may regulate chondrocyte prolif-
eration and differentiation indirectly by regulating IHH
signaling. In support of this model, Iwata et al. observed
increased chondrocyte proliferation and increased Patched
expression in E15.5 mice harboring an Fgfr3 gain of function
mutation (Iwata et al., 2000).
Delayed vascularization and osteoclast recruitment
Endochondral bone growth is a complex process that
involves three different but related developmental events:
chondrogenesis, vascularization and osteogenesis (Karsenty
and Wagner, 2002; Kronenberg, 2003; Ornitz, 2005; Ornitz and
Marie, 2002). Vascularization is essential to transform cartilage
matrix into trabecular bone by facilitating the influx of both
osteoblasts and osteoclasts. The observations that in Fgf18−/−
mice, osteoblast (Liu et al., 2002) and osteoclast markers (Fig.
5) are down-regulated in the trabecular region of developing
long bones, indicate that the influx of both osteoblasts and
osteoclasts is delayed in the absence of FGF18 signaling. The
delayed entry of the hematopoietic-derived osteoclast suggests
that a primary mechanism accounting for the delayed formation
of the ossification center in Fgf18−/− mice is a delay in
vascularization of the growth plate. Furthermore, since this
delay is not seen in Fgfr3−/− mice, it is likely that delayed
vascularization is mediated through FGFR1 and/or FGFR2
signaling in perichondrial tissue or FGFR1 signaling in
hypertrophic chondrocytes.
In addition to delayed vascularization, it is also possible that
maturation of the osteoclast is itself delayed. Osteoclasts
express Fgfr1 and could respond directly to FGF18; alterna-
tively, osteoclast maturation could be affected indirectly by
altered FGF-mediated cytokine production by osteoblasts
(Chikazu et al., 2000; Chikazu et al., 2001). However, the
decreased number of osteoclasts at the vascular front suggests
that delayed vascularization is the predominant factor delaying
skeletal vascularization in Fgf18−/− mice.VEGF and FGF signaling are two major pathways that
regulate vasculogenesis and angiogenesis (Cross and Claesson-
Welsh, 2001; Yancopoulos et al., 2000). VEGF signaling is
essential for the vascularization of developing cartilage
(Carlevaro et al., 2000; Gerber et al., 1999; Haigh et al.,
2000; Zelzer et al., 2002). The delayed skeletal vascularization
in Fgf18−/− mice could result from decreased FGF signaling
directly to endothelial cells or indirectly through regulation of
VEGF signaling. Embryos in which both Fgfr1 and Fgfr2
have been conditionally inactivated in endothelial cells
develop normally and are viable (Lavine et al., 2006). These
mice do not exhibit defects in skeletal vascularization (KJL
and DMO, unpublished observation), suggesting that FGF18
may regulate vascular growth indirectly by regulating Vegf
expression. Consistent with this model, we showed that in the
absence of FGF18, Vegf expression is decreased/delayed in
hypertrophic chondrocytes and Vegf receptor expression is
reduced in interdigital mesenchyme. Furthermore, we showed
that FGF18 was sufficient to induce Vegf expression in
chondrocytes and the perichondrium in a limb explant culture
system. The decreased Vegf expression in hypertrophic
chondrocytes could be either a direct effect of FGF18/
FGFR3 signaling or an indirect consequence of delayed
terminal differentiation of hypertrophic chondrocytes. In
support of this model, Amizuka et al. demonstrated that Vegf
expression was greatly reduced in Fgfr3−/− hypertrophic
chondrocytes (Amizuka et al., 2004).
Concluding remarks
Our previous studies (Liu et al., 2002) and data presented
here demonstrate that FGF18 regulates chondrocyte prolifera-
tion and differentiation by signaling to FGFR3 in proliferating
chondrocytes and osteogenesis by signaling to FGFR1 and/or
FGFR2 in the perichondrium/periosteum. Here we present
further evidence that FGF18 signaling is also important for
early chondrocyte proliferation, initiation of chondrocyte
hypertrophy and for vascularization of the growth plate.
FGF18 thus functions to coordinate the three critical develop-
mental stages of endochondral ossification by balancing the
developmental timing of chondrogenesis, osteogenesis and
vascularization.
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